
Tsingke Biotech Gathers Industry Leaders to Advance RNA Therapeutics
At the Hilton Shanghai Zhangjiang, experts from across the biopharmaceutical landscape convened to address the technical and regulatory hurdles facing oligonucleotide drugs. The salon, hosted by Tsingke Biotech, marked a strategic push to transition China’s nucleic acid sector from basic technology adoption toward high-level, innovation-driven clinical development.



























